Estimated burden of COVID-19 illnesses, medical visits, hospitalizations, and deaths in the US from October 2022 to September 2024

JAMA Internal Medicine

FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail

About The Study:

 In this cross-sectional study, despite declining from the first (October 2022 to September 2023) to the second (October 2023 to September 2024) surveillance period, the COVID-19 burden continued to have a large impact in the U.S., particularly among adults 65 years and older, underscoring the ongoing importance of prevention measures. 

Corresponding Author: To contact the corresponding author, Emilia H. A. Koumans, MD, email ekoumans@cdc.gov.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamainternmed.2025.7179)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article 

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2025.7179?guestAccessKey=c26397f8-3193-499d-a048-281b78b4d8b6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010526

---

Journal

JAMA Internal Medicine